Список литературы

Поставить закладку

Kitchens C.S. Disseminated Intravascular Coagulation. In: Kitchens C.S., ed. Consultative Hemostasis and Thrombosis. W.B.: Saunders Company; 2007. 165-178.
Ralph AG, Brainard BM. Update on disseminated intravascular coagulation: when to consider it, when to expect it, when to treat it. Top Companion Anim Med. 2012;27(2):65-72. doi:10.1053/j.tcam.2012.06.004
Asakura H. Classifying types of disseminated intravascular coagulation: clinical and animal models. J Intensive Care. 2014;2(1):20. Published 2014 Mar 6. doi:10.1186/2052-0492-2-20
Thachil J, Falanga A, Levi M, Liebman H, Di Nisio M; Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis. Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH. J Thromb Haemost. 2015;13(4):671-675. doi:10.1111/jth.12838
Kaneko T, Wada H. Diagnostic criteria and laboratory tests for disseminated intravascular coagulation. J Clin Exp Hematop. 2011;51(2):67-76. doi:10.3960/jslrt.51.67
Воробьева Н.А., Капустин С.И. Роль генетических полиморфизмов системы гемостаза в формировании полиорганной недостаточности при остром ДВС-синдроме. Анестезиология и реаниматология. 2007; №2: 52-55.
Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M; Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86(5):1327-1330.
Blasi A. Coagulopathy in liver disease: Lack of an assessment tool. World J Gastroenterol. 2015;21(35):10062-10071. doi:10.3748/wjg.v21.i35.10062
Uijttewaal WS, Nijhof EJ, Bronkhorst PJ, Den Hartog E, Heethaar RM. Near-wall excess of platelets induced by lateral migration of erythrocytes in flowing blood. Am J Physiol. 1993;264(4 Pt 2):H1239-H1244. doi:10.1152/ajpheart.1993.264.4.H1239
Peyrou V, Lormeau JC, Hérault JP, Gaich C, Pfliegger AM, Herbert JM. Contribution of erythrocytes to thrombin generation in whole blood. Thromb Haemost. 1999;81(3):400-406.
Sagesaka T. Influence of red blood cell concentration on the initiation time of blood coagulation: risk of thrombus formation by hemoconcentration. Clin Hemorheol Microcirc. 2004;31(4):243-249.
Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semin Thromb Hemost. 2004;30(5):579-589. doi:10.1055/s-2004-835678
Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20:100. Published 2016 Apr 12. doi:10.1186/s13054-016-1265-x
Dyer MR, Plautz WE, Ragni MV, et al. Traumatic injury results in prolonged circulation of ultralarge von Willebrand factor and a reduction in ADAMTS13 activity. Transfusion. 2020;60(6):1308-1318. doi:10.1111/trf.15856
Deloughery T.G. Hemorrhagic and Thrombotic Disorders in the Intensive Care Setting. In: Kitchens C.S., ed. Consultative Hemostasis and Thrombosis. W.B.: Saunders Company; 2007. 493-514.
Marcucci C.E., Schoettker P. Perioperative Hemostаsis. Springer; 2015. 454 s.
Antiphospholipid Syndrome: Insights and Highlights from the 13th International Congress on Antiphospholipid Antibodies D. Erkan and S.S. Pierangeli (eds.), DOI 10.1007/978-1-4614-3194-7_17, © Springer Science+Business Media New York 2012
Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295-306. doi:10.1111/j.1538-7836.2006.01753.x
Asherson RA, Cervera R, de Groot PG, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12(7):530-534. doi:10.1191/0961203303lu394oa
Kitchens C.S. Surgery and hemostasis. In: Kitchens C.S., ed. Consultative Hemostasis and Thrombosis. W.B.: Saunders Company; 2007. 463-480.
Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al. Guidelines for the management of hemophilia. Haemophilia. 2013;19(1):e1-e47. doi:10.1111/j.1365-2516.2012.02909.x
Blanchette VS, Key NS, Ljung LR, et al. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014;12(11):1935-1939. doi:10.1111/jth.12672
Laffan MA, Lester W, O'Donnell JS, et al. The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br J Haematol. 2014;167(4):453-465. doi:10.1111/bjh.13064
Suchman AL, Mushlin AI. How well does the activated partial thromboplastin time predict postoperative hemorrhage?. JAMA. 1986;256(6):750-753.
Narr BJ, Warner ME, Schroeder DR, Warner MA. Outcomes of patients with no laboratory assessment before anesthesia and a surgical procedure. Mayo Clin Proc. 1997;72(6):505-509.
Спиридонова Е.А., Щукин В.В., Жарков П.А., Атауллаханов Ф.И., Зейналов А.М., Баландина А.Н., Карелин А.Ф., Шимширт М.А., Сманцер В.А., Селиванов В.В., Овсянников Ю.Г. Периоперационный гемостазиологический мониторинг: цель и лабораторное сопровождение. Вестник интенсивной терапии 2016; 1:37-46
Заболотских И.Б., Синьков С.В., Лебединский К.М., Буланов А.Ю. Периоперационное ведение больных с нарушениями системы гемостаза// Вестник интенсивной терапии.-2015.-№ 1.-С. 65-77.
Amgalan A, Allen T, Othman M, Ahmadzia HK. Systematic review of viscoelastic testing (TEG/ROTEM) in obstetrics and recommendations from the women's SSC of the ISTH. J Thromb Haemost. 2020 Aug;18(8):1813-1838. http://doi:10.1111/jth.14882.
de Lange NM, van Rheenen-Flach LE, Lancé MD, Mooyman L, Woiski M, van Pampus EC, Porath M, Bolte AC, Smits L, Henskens YM, Scheepers HC. Peri-partum reference ranges for ROTEM(R) thromboelastometry. Br J Anaesth. 2014 May;112(5):852-9. http://doi:10.1093/bja/aet480.
Bugaev N, Como JJ, Golani G, Freeman JJ, et al. Thromboelastography and rotational thromboelastometry in bleeding patients with coagulopathy: Practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2020 Dec;89(6):999-1017. http://doi:10.1097/TA.0000000000002944.
Ramler PI, Gillissen A, Henriquez DDCA, Caram-Deelder C, et al. Clinical value of early viscoelastometric point-of-care testing during postpartum hemorrhage for the prediction of severity of bleeding: A multicenter prospective cohort study in the Netherlands. Acta Obstet Gynecol Scand. 2021 Sep;100(9):1656-1664. http://doi:10.1111/aogs.14172. Epub 2021 Jun 19.
Shamshirsaz AA, Fox KA, Erfani H, Bruzdoski K, et al. Trimester-specific thromboelastic values and coagulation activation markers in pregnancy compared across trimesters and compared to the nonpregnant state. Int J Lab Hematol. 2021 Oct;43(5):1216-1224. http://doi:10.1111/ijlh.13472.
Tanaka KA, Henderson RA, Strauss ER. Evolution of viscoelastic coagulation testing. Expert Rev Hematol. 2020 Jul;13(7):697-707. http://doi:10.1080/17474086.2020.1758929.
Fahrendorff M, Oliveri RS, Johansson PI. The use of viscoelastic haemostatic assays in goal-directing treatment with allogeneic blood products-A systematic review and meta-analysis. Scand J Trauma Resusc Emerg Med. 2017 Apr 13;25(1):39. http://doi:10.1186/s13049-017-0378-9.
Роненсон А.М., Шифман Е.М., Куликов А.В., Распопин Ю.С. Референсные показатели ротационной тромбоэластометрии у беременных и рожениц: систематический обзор и метаанализ. Анестезиология и реаниматология. 2021;3:28–40. https://http://doi.org/10.17116/anaesthesiology202103128
Shenoy A, Louissaint J, Shannon C, Tapper EB, Lok AS. Viscoelastic Testing Prior to Non-surgical Procedures Reduces Blood Product Use Without Increasing Bleeding Risk in Cirrhosis. Dig Dis Sci. 2022 Nov;67(11):5290-5299. doi: 10.1007/s10620-021-07376-6. Epub 2022 Feb 5
Mpaili E, Tsilimigras DI, Moris D, Sigala F, Frank SM, Hartmann J, Pawlik TM. Utility of viscoelastic coagulation testing in liver surgery: a systematic review. HPB (Oxford). 2021 Mar;23(3):331-343. doi: 10.1016/j.hpb.2020.10.023.
Weber CF, Görlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology. 2012;117(3):531-547. doi:10.1097/ALN.0b013e318264c644
Karkouti K, McCluskey SA, Callum J, et al. Evaluation of a novel transfusion algorithm employing point-of-care coagulation assays in cardiac surgery: a retrospective cohort study with interrupted time-series analysis. Anesthesiology. 2015;122(3):560-570. doi:10.1097/ALN.0000000000000556
Girdauskas E, Kempfert J, Kuntze T, et al. Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: a prospective, randomized trial. J Thorac Cardiovasc Surg. 2010;140(5):1117-24.e2. doi:10.1016/j.jtcvs.2010.04.043
Буланов А. Ю. Тромбоэластография в современной клинической практике: атлас ТЭГ. Москва : Ньюдиамед, 2015.-114 с.
da Luz LT, Nascimento B, Rizoli S. Thrombelastography (TEG®): practical considerations on its clinical use in trauma resuscitation. Scand J Trauma Resusc Emerg Med. 2013;21:29. Published 2013 Apr 16. doi:10.1186/1757-7241-21-29
Trzebicki J, Flakiewicz E, Kosieradzki M, et al. The use of thromboelastometry in the assessment of hemostasis during orthotopic liver transplantation reduces the demand for blood products. Ann Transplant. 2010;15(3):19-24.
Walker C, Ingram M, Edwards D, Wood P. Use of thromboelastometry in the assessment of coagulation before epidural insertion after massive transfusion. Anaesthesia. 2011;66(1):52-55. doi:10.1111/j.1365-2044.2010.06500.x
Doran CM, Woolley T, Midwinter MJ. Feasibility of using rotational thromboelastometry to assess coagulation status of combat casualties in a deployed setting. J Trauma. 2010;69 Suppl 1:S40-S48. doi:10.1097/TA.0b013e3181e4257b
Lee SH, Lee SM, Kim CS, et al. Use of fibrin-based thromboelastometry for cryoprecipitate transfusion in cardiac surgery involving deep hypothermic circulatory arrest during cardiopulmonary bypass. Blood Coagul Fibrinolysis. 2010;21(7):687-691. doi:10.1097/MBC.0b013e32833e4228
Буланов А.Ю., Яцков К.В., Буланова Е.Л., Доброва Н.В. Тромбоэластография: клиническая значимость теста на функциональный фибриноген. Вестник интенсивной терапии 2017; 1:5-11
Baksaas-Aasen K, Gall LS, Stensballe J, et al. Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial. Intensive Care Med. 2021;47(1):49-59. doi:10.1007/s00134-020-06266-1
Синьков С.В., Заболотских И.Б. Алгоритм дифференциальной диагностики периоперационных нарушений гемостаза // Тромбоз, гемостаз и реология.-2016.-Т. 67. № S3.-С. 381-382.
Заболотских И.Б., Синьков С.В., Шапошников С.А. Приобретенные коагулопатии: современные подходы к дифференциальной диагностике и интенсивной терапии с позиций доказательной медицины // Общая реаниматология. – 2007.-№5-6. – С.192-198.
Wada H, Thachil J, Di Nisio M, et al. Harmonized guidance for disseminated intravascular coagulation from the International Society on Thrombosis and Haemostasis and the current status of anticoagulant therapy in Japan: a rebuttal. J Thromb Haemost. 2013;11(11):2078-2079. doi:10.1111/jth.12366
Тромбоз и гемостаз. Шкалы и алгоритмы (пособие под ред. Ройтмана Е.В. и Левшина Н.Ю.). М:2016. 62 с.
Заболотских И.Б., Синьков С.В., Аверьянова Л.Е. Синдром диссеминированного внутрисосудистого свертывания крови: диагностика и интенсивная терапия // Анестезиология и реаниматология. – 2007.-№2. – С.71-76.
Заболотских И.Б., Синьков С.В., Шапошников С.А. Роль инструментальных методов диагностики в оценке степени дисфункции системы гемостаза // Вестник интенсивной терапии. – 2009.-№5.-С.102-105.
Синьков С.В., Жилин И.В., Заболотских И.Б. Прогнозирование различных форм послеоперационной острой печеночной недостаточности // Анестезиология и реаниматология.-2017.-Т.62, №1.-С. 73-76.
Синьков С.В. Характер нарушений системы гемостаза у пациентов с хронической печеночной недостаточностью // Вестник хирургической гастроэнтерологии.-2017.- № 2.-С. 23-27.
Lange NW, Salerno DM, Berger K, Cushing MM, Brown RS Jr. Management of Hepatic Coagulopathy in Bleeding and Nonbleeding Patients: An Evidence-Based Review. J Intensive Care Med. 2021;36(5):524-541. doi:10.1177/0885066620903027
Stravitz RT, Lisman T, Luketic VA, et al. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol. 2012;56(1):129-136. doi:10.1016/j.jhep.2011.04.020
Agarwal B, Wright G, Gatt A, et al. Evaluation of coagulation abnormalities in acute liver failure. J Hepatol. 2012;57(4):780-786. doi:10.1016/j.jhep.2012.06.020
Заболотских И.Б., Киров М.Ю., Афончиков В.С. и соавт. Периоперационное ведение пациентов, получающих длительную антитромботическую терапию. Методические рекомендации Общероссийской общественной организации «Федерация анестезиологов и реаниматологов». Вестник интенсивной терапии имени А.И. Салтанова. 2021;(3):7–26. doi:10.21320/1818-474X-2021-3-7-26.
Consunji R, Elseed A, El-Menyar A, Sathian B, Rizoli S, Al-Thani H, Peralta R. The effect of massive transfusion protocol implementation on the survival of trauma patients: a systematic review and meta-analysis. Blood Transfus. 2020 Nov;18(6):434-445. doi: 10.2450/2020.0065-20.
Sommer N, Schnüriger B, Candinas D, Haltmeier T. Massive transfusion protocols in nontrauma patients: A systematic review and meta-analysis. J Trauma Acute Care Surg. 2019 Mar;86(3):493-504. doi:10.1097/TA.0000000000002101.
Mitra B, O'Reilly G, Cameron PA, Zatta A, Gruen RL. Effectiveness of massive transfusion protocols on mortality in trauma: a systematic review and meta-analysis. ANZ J Surg. 2013 Dec;83(12):918-23. doi: 10.1111/ans.12417.
Bhangu A, Nepogodiev D, Doughty H, Bowley DM. Meta-analysis of plasma to red blood cell ratios and mortality in massive blood transfusions for trauma. Injury. 2013 Dec;44(12):1693-9. doi:10.1016/j.injury.2012.07.193.
Enticott JC, Jeffcott S, Ibrahim JE, Wood EM, Cole-Sinclair M, Fitzgerald M, Cameron PA, Phillips LE. A review on decision support for massive transfusion: understanding human factors to support the implementation of complex interventions in trauma. Transfusion. 2012 Dec;52(12):2692-705. doi:10.1111/j.1537-2995.2012.03648.x.
Lier H, Böttiger BW, Hinkelbein J, Krep H, Bernhard M. Coagulation management in multiple trauma: a systematic review. Intensive Care Med. 2011 Apr;37(4):572-82. doi:10.1007/s00134-011-2139-y.
Wada H, Asakura H, Okamoto K, et al. Expert consensus for the treatment of disseminated intravascular coagulation in Japan. Thromb Res. 2010;125(1):6-11. doi:10.1016/j.thromres.2009.08.017
Wada H, Thachil J, Di Nisio M, et al. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost. 2013;10.1111/jth.12155. doi:10.1111/jth.12155
Kawasugi K, Wada H, Hatada T, et al. Prospective evaluation of hemostatic abnormalities in overt DIC due to various underlying diseases. Thromb Res. 2011;128(2):186-190. doi:10.1016/j.thromres.2011.02.015
Заболотских И.Б., Синьков С.В., Шапошников С.А. Выбор антикоагулянта в зависимости от стадии ДВС-синдрома // Анестезиология и реаниматология. – 2004.-№3. – с.29-31.
Cao Z, Li Q, Guo J, Li Y, Wu J. Optimal administration strategies of tranexamic acid to minimize blood loss during spinal surgery: results of a Bayesian network meta-analysis. Ann Med. 2022 Dec;54(1):2053-2063. doi:10.1080/07853890.2022.2101687.
Tran QK, Tang K, Pourmand A. Tranexamic acid and Gastrointestinal bleed: Effect of the HALT-IT trial on current meta-analysis. Am J Emerg Med. 2022 Sep;59:165-167. doi:10.1016/j.ajem.2022.06.050.
Fowler H, Law J, Tham SM, Gunaravi SA, Houghton N, Clifford RE, Fok M, Barker JA, Vimalachandran D. Impact on blood loss and transfusion rates following administration of tranexamic acid in major oncological abdominal and pelvic surgery: A systematic review and meta-analysis. J Surg Oncol. 2022 Sep;126(3):609-621. doi: 10.1002/jso.26900.
Ageron FX, Shakur-Still H, Roberts I. Effects of tranexamic acid treatment in severely and non-severely injured trauma patients. Transfusion. 2022 Aug;62 Suppl 1(Suppl 1):S151-S157. doi: 10.1111/trf.16954.
Laikhter E, Comer CD, Shiah E, Manstein SM, Bain PA, Lin SJ. A Systematic Review and Meta-Analysis Evaluating the Impact of Tranexamic Acid Administration in Aesthetic Plastic Surgery. Aesthet Surg J. 2022 Apr 12;42(5):548-558. doi: 10.1093/asj/sjab333.
Koh A, Adiamah A, Gomez D, Sanyal S. Safety and Efficacy of Tranexamic Acid to Minimise Perioperative Bleeding in Hepatic Surgery: A Systematic Review and Meta-Analysis. World J Surg. 2022 Feb;46(2):441-449. doi: 10.1007/s00268-021-06355-2.
Heyns M, Knight P, Steve AK, Yeung JK. A Single Preoperative Dose of Tranexamic Acid Reduces Perioperative Blood Loss: A Meta-analysis. Ann Surg. 2021 Jan 1;273(1):75-81. doi: 10.1097/SLA.0000000000003793.
Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med. 2007;356(22):2301-2311. doi:10.1056/NEJMra067742
Gando S, Wada H, Thachil J; Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis (ISTH). Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS). J Thromb Haemost. 2013;11(5):826-835. doi:10.1111/jth.12190
Di Nisio M, Baudo F, Cosmi B, et al. Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res. 2012;129(5):e177-e184. doi:10.1016/j.thromres.2011.08.028
Синьков С.В., Полин Е.В., Аверьянова Л.Е. Оптимизация выбора доз ингибиторов протеаз при фибринолитическом варианте ДВС-синдрома // Вестник интенсивной терапии. – 2005.-№5. – с. 210-215.
Pernerstorfer T, Hollenstein U, Hansen J, et al. Heparin blunts endotoxin-induced coagulation activation. Circulation. 1999;100(25):2485-2490. doi:10.1161/01.cir.100.25.2485
Warren BL, Eid A, Singer P, et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial [published correction appears in JAMA 2002 Jan 9;287(2):192]. JAMA. 2001;286(15):1869-1878. doi:10.1001/jama.286.15.1869
Aoki N, Matsuda T, Saito H, et al. A comparative double-blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation. Int J Hematol. 2002;75(5):540-547. doi:10.1007/BF02982120
Saito H, Maruyama I, Shimazaki S, et al. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost. 2007;5(1):31-41. doi:10.1111/j.1538-7836.2006.02267.x
Youssef WI, Salazar F, Dasarathy S, Beddow T, Mullen KD. Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study. Am J Gastroenterol. 2003;98(6):1391-1394. doi:10.1111/j.1572-0241.2003.07467.x
Stravitz RT, Kramer AH, Davern T, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007;35(11):2498-2508. doi:10.1097/01.CCM.0000287592.94554.5F
Pereira SP, Langley PG, Williams R. The management of abnormalities of hemostasis in acute liver failure. Semin Liver Dis. 1996;16(4):403-414. doi:10.1055/s-2007-1007253
Chowdary P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol. 2004;125(1):69-73. doi:10.1111/j.1365-2141.2004.04868.x
Giannini EG, Greco A, Marenco S, Andorno E, Valente U, Savarino V. Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease. Clin Gastroenterol Hepatol. 2010;8(10):899-e109. doi:10.1016/j.cgh.2010.06.018
Segal JB, Dzik WH; Transfusion Medicine/Hemostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion. 2005;45(9):1413-1425. doi:10.1111/j.1537-2995.2005.00546.x
O'Shaughnessy DF, Atterbury C, Bolton Maggs P, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol. 2004;126(1):11-28. doi:10.1111/j.1365-2141.2004.04972.x
Lorenz R, Kienast J, Otto U, et al. Efficacy and safety of a prothrombin complex concentrate with two virus-inactivation steps in patients with severe liver damage. Eur J Gastroenterol Hepatol. 2003;15(1):15-20.
Kuroda S, Kobayashi T, Tashiro H, et al. A multicenter randomized controlled trial comparing administration of antithrombin III after liver resection (HiSCO-05 trial). Surgery. 2021;170(4):1140-1150. doi:10.1016/j.surg.2021.03.057
Porte RJ, Molenaar IQ, Begliomini B, et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomized double-blind study. EMSALT Study Group. Lancet. 2000;355(9212):1303-1309.
Boylan JF, Klinck JR, Sandler AN, et al. Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology. 1996;85(5):1043-1048.
Hendriks HG, Meijer K, de Wolf JT, et al. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study. Transplantation. 2001;71(3):402-405.
Lodge JP, Jonas S, Jones RM, et al. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transpl. 2005;11(8):973-979.
Planinsic R, van der Meer J, Testa G, et al. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl. 2005; 11(8):895-900.
Hedges SJ, Dehoney SB, Hooper JS, Amanzadeh J, Busti AJ. Evidencebased treatment recommendations for uremic bleeding. Nat Clin Pract Nephrol 2007; 3:138–153.
Manno C, Bonifati C, Torres DD, Campobasso N, Schena FP. Desmopressin acetate in percutaneous ultrasound-guided kidney biopsy: a randomized controlled trial. Am J Kidney Dis 2011; 57:850–855.
Vigano G, Gaspari F, Locatelli M, Pusineri F, Bonati M, Remuzzi G. Doseeffect and pharmacokinetics of estrogens given to correct bleeding time in uremia. Kidney Int 1988; 34:853–858.
Holcomb JB, Jenkins D, Rhee P, Johannigman J, Mahoney P, Mehta S, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007;62(2):307–10.
Dente CJ, Shaz BH, Nicholas JM, Harris RS, Wyrzykowski AD, Patel S, et al. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma. 2009;66(6):1616–24.
Bulger EM, May S, Brasel KJ, Schreiber M, Kerby JD, Tisherman SA, et al. Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA. 2010;304(13):1455–64.
Ketchum L, Hess JR, Hiippala S. Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma. J Trauma. 2006;60(6 Suppl):S51–8.
Holcomb JB, Hess JR. Early massive trauma transfusion: state of the art: editor’s introduction. J Trauma Acute Care Surg. 2006;60(6):S1–2.
Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471–82.
Baraniuk S, Tilley BC, del Junco DJ, Fox EE, van Belle G, Wade CE, et al. Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: design, rationale and implementation. Injury. 2014;45(9):1287–95.
Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, et al. Transfusion-related acute lung injury: definition and review. Crit Care Med. 2005;33(4):721–6.
Holness L, Knippen MA, Simmons L, Lachenbruch PA. Fatalities caused by TRALI. Transfus Med Rev. 2004;18(3):184–8.
Jost D, Lemoine S, Lemoine F, et al. Prehospital Lyophilized Plasma Transfusion for Trauma-Induced Coagulopathy in Patients at Risk for Hemorrhagic Shock: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(7):e2223619. Published 2022 Jul 1. doi:10.1001/jamanetworkopen.2022.23619
Kao TW, Lee YC, Chang HT. Prothrombin Complex Concentrate for Trauma Induced Coagulopathy: A Systematic Review and Meta-Analysis. J Acute Med. 2021;11(3):81-89. doi:10.6705/j.jacme.202109_11(3).0001
CRASH-2 Trial Collaborators, Shakur H, Roberts I, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo controlled trial. Lancet. 2010; 376:23e32.
Biffi A, Porcu G, Castellini G, Napoletano A, Coclite D, D'Angelo D, Fauci AJ, Iacorossi L, Latina R, Salomone K, Iannone P, Gianola S, Chiara O; Italian National Institute of Health Guideline Working Group. Systemic hemostatic agents initiated in trauma patients in the pre-hospital setting: a systematic review. Eur J Trauma Emerg Surg. 2022 Dec 16. doi: 10.1007/s00068-022-02185-6
Al-Jeabory M, Szarpak L, Attila K, Simpson M, Smereka A, Gasecka A, Wieczorek W, Pruc M, Koselak M, Gawel W, Checinski I, Jaguszewski MJ, Filipiak KJ. Efficacy and Safety of Tranexamic Acid in Emergency Trauma: A Systematic Review and Meta-Analysis. J Clin Med. 2021 Mar 3;10(5):1030. doi: 10.3390/jcm10051030.
Roberts I, Shakur H, Afolabi A et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011; 377(9771):1096–101.1101e1091–1092.
July J, Pranata R. Tranexamic acid is associated with reduced mortality, hemorrhagic expansion, and vascular occlusive events in traumatic brain injury-meta-analysis of randomized controlled trials. BMC Neurol. 2020;20(1):119. Published 2020 Apr 6. doi:10.1186/s12883-020-01694-4
Coburn W, Trottier Z, Villarreal RI, Paulson MW, Woodard SC, McKay JT, Bebarta VS, Flarity K, Keenan S, Schauer SG. Prehospital Pharmacotherapy in Moderate and Severe Traumatic Brain Injury: A Systematic Review. Med J (Ft Sam Houst Tex). 2023 Jan-Mar;(Per 23-1/2/3):47-56.
Huang H, Xin M, Wu X, Liu J, Zhang W, Yang K, Zhang J. The efficacy of tranexamic acid treatment with different time and doses for traumatic brain injury: a systematic review and meta-analysis. Thromb J. 2022 Dec 19;20(1):79. doi: 10.1186/s12959-022-00440-9.
Devereaux PJ, Marcucci M, Painter TW, et al. Tranexamic Acid in Patients Undergoing Noncardiac Surgery. N Engl J Med. 2022;386(21):1986-1997. doi:10.1056/NEJMoa2201171
Roberts I, Shakur H, Ker K et al. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev. 2012; 12:CD004896.
Roberts I, Prieto-Merino D, Manno D. Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial. Crit Care. 2014; 18(6):685.
Roberts I, Perel P, Prieto-Merino D et al. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial. BMJ. 2012; 345:e5839.
Kozek-Langenecker SA, Ahmed AB., Afshari A et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2017; 34:332–395
Афончиков В.С., Михеева А.В. Гиперфибринолиз и ретракция сгустка крови при шокогенной травме. Вестник интенсивной терапии 2016; 3:47-52
Gayet-Ageron A, Prieto-Merino D, Ker K et al. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40138 bleeding patients. Lancet.2018 Jan 13;391(10116): 125–132.
Schöchl H, Nienaber U, Hofer G et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEMW)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010, 14:R55.
Shaz BH, Dente CJ, Nicholas J et al. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion. 2010; 50(2):493–500.
Morrow GB, Feller T, McQuilten Z, et al. Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: Results from a laboratory sub-study of the FEISTY trial. Crit Care. 2022;26(1):290. Published 2022 Sep 26. doi:10.1186/s13054-022-04167-x
Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg. 1995;81(2):360–5.
Schöchl H, Cotton B, Inaba K, et al. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care. 2011; 15(6):R265.
Stinger HK, Spinella PC, Perkins JG et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. Journal of Trauma 2008; 64(2 Suppl):S79–85. 
Schöchl H, Nienaber U, Maegele M et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care. 2011; 15(2):R83.
Nardi G, Agostini V, Rondinelli B et al. Traumainduced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. Crit Care. 2015; 19(1):83.
Ziegler B, Bachler M, Haberfellner H, et al. Efficacy of prehospital administration of fibrinogen concentrate in trauma patients bleeding or presumed to bleed (FIinTIC): A multicentre, double-blind, placebo-controlled, randomised pilot study. Eur J Anaesthesiol. 2021;38(4):348-357. doi:10.1097/EJA.0000000000001366
Stansbury LG, Hess AS, Thompson K et al. The clinical significance of platelet counts in the first 24 hours after severe injury. Transfusion. 2013; 53(4):783–9.
Joseph B, Aziz H, Zangbar B et al. Acquired coagulopathy of traumatic brain injury defined by routine laboratory tests: which laboratory values matter? J Trauma Acute Care Surg. 2014; 76(1):121–5.
Kashuk JL, Moore EE, Johnson JL et al. Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma:packed red blood cells the answer? Journal of Trauma 2008; 65(2):261– 270.
Nekludov M, Bellander BM, Blomback M, Wallen HN. Platelet dysfunction in patients with severe traumatic brain injury. J Neurotrauma. 2007; 24(11):1699–706.
Wohlauer MV, Moore EE, Thomas S et al. Early platelet dysfunction: an unrecognized role in the acute coagulopathy of trauma. J Am Coll Surg. 2012; 214(5):739–46.
Counts RB, Haisch C, Simon TL et al. Hemostasis in massively transfused trauma patients. Ann Surg. 1979; 190(1):91–9.
Ciavarella D, Reed RL, Counts RB et al. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol. 1987; 67(3):365– 8.
Johansson PI, Stensballe J, Rosenberg I et al. Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice. Transfusion. 2007; 47(4):593–8.
Holcomb JB, Wade CE, Michalek JE et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008; 248(3):447–58.
Zink KA, Sambasivan CN, Holcomb JB et al. A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. Am J Surg. 2009; 197(5):565–70. discussion 570.
McQuilten ZK, Crighton G, Engelbrecht et al. Transfusion interventions in critical bleeding requiring massive transfusion: a systematic review. Transfus Med Rev. 2015; 29(2):127–37.
Quinlan DJ, Eikelboom JW, Weitz JI. Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding. Circulation. 2013; 128(11):1179–81.
Sarode R, Milling Jr TJ, Refaai MA et al. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation. 2013; 128(11):1234–43.
Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation. 2011;124(14):1573–9.
Marlu R, Hodaj E, Paris A, Albaladejo P, Crackowski JL, Pernod G. Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. Thromb Haemost. 2012;108(2):217–24.
Goldstein JN, Refaai MA, Milling Jr TJ et al. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. Lancet. 2015; 385(9982):2077–87.
Huttner HB, Schellinger PD, Hartmann M et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke. 2006; 37(6):1465–70.
Edavettal M, Rogers A, Rogers F et al. Prothrombin complex concentrate accelerates international normalized ratio reversal and diminishes the extension of intracranial hemorrhage in geriatric trauma patients. Am Surg. 2014; 80(4):372–6.
Baglin TP, Keeling DM, Watson HG. Guidelines on oral anticoagulation (warfarin): third edition–2005 update. Br J Haematol. 2006; 132(3):277–85.
Clave A, Fazilleau F, Dumser D, Lacroix J. Efficacy of tranexamic acid on blood loss after primary cementless total hip replacement with rivaroxaban thromboprophylaxis: a case-control study in 70 patients. Orthop Traumatol Surg Res. 2012;98(5):484–90.
Hosseini SF, Behnam-Roudsari S, Alavinia G, et al. Diagnostic and prognostic value of Sepsis-Induced coagulopathy and International Society on Thrombosis and Hemostasis scoring systems in COVID-19-associated disseminated intravascular coagulopathy. J Res Med Sci. 2021;26:102. Published 2021 Oct 18. doi:10.4103/jrms.JRMS_1295_20
Lee DH, Lee BK, Jeung KW, Park JS, et al. Performance of 5 disseminated intravascular coagulation score systems in predicting mortality in patients with severe trauma. Medicine (Baltimore). 2018 Aug;97(33):e11912. http://doi:10.1097/MD.0000000000011912.
Asakura H, Takahashi H, Uchiyama T, Eguchi Y, et al. DIC subcommittee of the Japanese Society on Thrombosis and Hemostasis. Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J. 2016 Sep 28;14:42. http://doi:10.1186/s12959-016-0117-x.
Thrombosis and Hemostasis group, Hematology Society, Chinese Medical Association. [Consensus of Chinese experts on diagnosis and treatment of disseminated intravascular coagulation (version 2012)]. Zhonghua Xue Ye Xue Za Zhi. 2012 Nov;33(11):978-9. Chinese.
Saito S, Uchino S, Hayakawa M, Yamakawa K, et al. Japan Septic Disseminated Intravascular Coagulation (JSEPTIC DIC) study group. Epidemiology of disseminated intravascular coagulation in sepsis and validation of scoring systems. J Crit Care. 2019 Apr;50:23-30. http://doi:10.1016/j.jcrc.2018.11.009.
Frank CS, Larsen JB. Prognostic Impact of the International Society on Thrombosis and Hemostasis Disseminated Intravascular Coagulation Score in Sepsis: A Systematic Review. Semin Thromb Hemost. 2023 Feb 2. doi: 10.1055/s-0043-1761216.
Iba T, Connors JM, Nagaoka I, Levy JH. Recent advances in the research and management of sepsis-associated DIC. Int J Hematol. 2021;113(1):24-33. doi:10.1007/s12185-020-03053-y
Iba T, Levi M, Thachil J, Helms J, Scarlatescu E, Levy JH. Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis. J Thromb Haemost. 2023 Jan;21(1):145-153. doi: 10.1016/j.jtha.2022.10.022.
Kudo D, Goto T, Uchimido R, et al. Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin: an analysis of three multicentre observational studies. Crit Care. 2021;25(1):114. Published 2021 Mar 19. doi:10.1186/s13054-021-03541-5
Lippi G, Henry BM, Sanchis-Gomar F. Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness. Semin Thromb Hemost. 2021 Jun;47(4):460-462. doi: 10.1055/s-0040-1716873.
Wiedermann CJ. Antithrombin concentrate use in disseminated intravascular coagulation of sepsis: meta-analyses revisited. J Thromb Haemost. 2018 Mar;16(3):455-457. doi: 10.1111/jth.13950
Allingstrup M, Wetterslev J, Ravn FB, Møller AM, Afshari A. Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2016 Apr;42(4):505-520. doi: 10.1007/s00134-016-4225-7
Czempik PF, Wiórek A. Management Strategies in Septic Coagulopathy: A Review of the Current Literature. Healthcare (Basel). 2023 Jan 12;11(2):227. doi: 10.3390/healthcare11020227.
Catenacci V, Sheikh F, Patel K, Fox-Robichaud AE. The prognostic utility of protein C as a biomarker for adult sepsis: a systematic review and meta-analysis. Crit Care. 2022;26(1):21. Published 2022 Jan 14. doi:10.1186/s13054-022-03889-2
Boscolo A, Spiezia L, De Cassai A, et al. Are thromboelastometric and thromboelastographic parameters associated with mortality in septic patients? A systematic review and meta-analysis. J Crit Care. 2021;61:5-13. doi:10.1016/j.jcrc.2020.09.034
British Committee for Standards in Haematology. Guidelines for the use of platelet transfusions. British Journal of Haematology, 2017; 176: 365–394.
Клинические рекомендации по диагностике и лечению атипичного гемолитикоуремического синдрома. Научное общество нефрологов России, 2015.
Cuker A, Arepally GM, Chong BH, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018;2(22):3360-3392. doi:10.1182/bloodadvances.2018024489
Warkentin T., Greinacher A. (Eds.). (2003). Heparin-Induced Thrombocytopenia (3rd ed.). CRC Press. https://doi.org/10.1201/9780824758844
Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy [published correction appears in Chest. 2005 Jan;127(1):416]. Chest. 2004;126(3 Suppl):311S-337S. doi:10.1378/chest.126.3_suppl.311S
Finazzi G, Marchioli R, Brancaccio V, etal. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J .Thromb. Haemost. 2005,3,848– 853.
Urbanus RT, Siegerink B, Roest M, Rosendaal FR, De Groot PG, Algra A. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case–control study. Lancet Neurol. 2009,8,998–1005.
Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore). 2001,80,355–376.
Erkan D. Therapeutic and prognostic considerations in catastrophic antiphospholipid syndrome. Autoimmun. Rev. 2006,6,98–103.
Решетняк Т.М. Лечение антифосфолипидного синдрома: современные стандарты. Тромбоз, гемостазиреология. 2016; №1: 11-20.
Wu X, Cao S, Yu B, He T. Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis. Blood Coagul Fibrinolysis. 2022 Oct 1;33(7):389-401. doi: 10.1097/MBC.0000000000001153.
Pastori D, Menichelli D, Cammisotto V, Pignatelli P. Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines. Front Cardiovasc Med. 2021 Aug 3;8:715878. doi: 10.3389/fcvm.2021.715878
Tektonidou MG, Andreoli L, Limper M, Tincani A, Ward MM. Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults. RMD Open. 2019 Apr 28;5(1):e000924. doi: 10.1136/rmdopen-2019-000924.
Bala MM, Paszek E, Lesniak W, Wloch-Kopec D, Jasinska K, Undas A. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies. Cochrane Database Syst Rev. 2018 Jul 13;7(7):CD012534. doi: 10.1002/14651858.CD012534.pub2.
Silva FF, Carvalho JF. Intensity of anticoagulation in the treatment of thrombosis in the antiphospholipid syndrome: a meta-analysis. Rev Bras Reumatol. 2015 Mar-Apr;55(2):159-66. doi: 10.1016/j.rbr.2014.08.016.
Reynaud Q, Lega JC, Mismetti P, Chapelle C, Wahl D, Cathébras P, Laporte S. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis. Autoimmun Rev. 2014 Jun;13(6):595-608. doi: 10.1016/j.autrev.2013.11.004
Ruiz-Irastorza G, Hunt BJ, Khamashta MA. A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis Rheum. 2007 Dec 15;57(8):1487-95. doi: 10.1002/art.23109.
Shibuya M, Kimura Y, Takuma S, Kamekura N, Fujisawa T. Cardiovascular Considerations in Anesthetic Management for a Patient With Antiphospholipid Syndrome and Decreased Cardiac Function: A Case Study. Anesth Prog. 2021 Mar 1;68(1):33-37. doi: 10.2344/anpr-67-03-07. 43.
Miller's Anesthesia, 2-Volume Set 9th Ed. /Editors: M. Gropper, L. Eriksson, L.Fleisher, J. Wiener-Kronish, N. Cohen, K. Leslie-Elsevier;-2019-3112 p
Stoelting's anesthesia and co-existing disease, seventh edition/ R. L. Hines, K.E. Marschall.-by Elsevier, Inc.-2018-740 p.
Hermans C, Altisent C, Batorova A, et al. Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations. Haemophilia 2009; 15:639–658.
Mauser-Bunschoten EP, Kleine Budde I, Lopaciuk S, et al. An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact(R)), results of phase III and IV clinical studies. Haemophilia 2011; 17:439–445.
Strauss T, Lubetsky A, Ravid B, et al. Recombinant factor concentrates may increase inhibitor development: a single centre cohort study. Haemophilia 2011; 17:625–629.
Pruthi RK, Mathew P, Valentino LA, et al. Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial. Thromb Haemost 2007; 98:726–732.
Iorio A, Matino D, D’Amico R, Makris M. Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors. Cochrane Database Syst Rev 2010; (8):CD004449.
Hvas AM, Sorensen HT, Norengaard L, Christiansen K, Ingerslev J, Sorensen B. Tranexamic acid combined with recombinant factor VIII increases clot resistance to accelerated fibrinolysis in severe hemophilia A. J Thromb Haemost 2007; 5:2408–2414.
Togioka BM, Burwick RM, Kujovich JL. Delivery and neuraxial technique outcomes in patients with hemophilia and in hemophilia carriers: a systematic review. J Anesth. 2021 Apr;35(2):288-302. doi: 10.1007/s00540-021-02911-1.
Choi S, Brull R. Neuraxial techniques in obstetric and non-obstetric patients with common bleeding diatheses. Anesth Analg. 2009 Aug;109(2):648-60. doi: 10.1213/ane.0b013e3181ac13d1.
Moharrami A, Mafi AH, Fallah E, Salehi M, Mortazavi SMJ. Total joint arthroplasty in the patients with haemophilia: General or neuraxial anaesthesia? Haemophilia. 2022 Jul;28(4):e95-e97. doi: 10.1111/hae.14509. Memtsoudis SG, Cozowicz C, Bekeris J, Bekere D, et al. Anaesthetic care of patients undergoing primary hip and knee arthroplasty: consensus recommendations from the International Consensus on Anaesthesia-Related Outcomes after Surgery group (ICAROS) based on a systematic review and meta-analysis. Br J Anaesth. 2019 Sep;123(3):269-287. doi: 10.1016/j.bja.2019.05.042.
Cesur S, Gürkan Y, Türkyılmaz N, Kuş A, Aksu C. Erişkin hemofili hastasında ultrason rehberliğinde penil blok ile cerrahi anestezi [Surgical anesthesia using ultrasound-guided penile nerve block for adult hemophilia patient]. Agri. 2020 Aug;32(3):162-163. Turkish. doi: 10.5505/agri.2018.27676.
Li S, Qu B, Ma W, Li Y. Perioperative anaesthesia and coagulation management of haemophilia patients receiving total hip and knee replacement arthroplasty: Experience from a case series. J Orthop Surg (Hong Kong). 2019 Sep-Dec;27(3):2309499019874931. doi: 10.1177/2309499019874931.
Coppola A, Windyga J, Tufano A, et al. Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery. Cochrane Database Syst Rev 2015; (2):CD009961.
Santagostino E, Escobar M, Ozelo M, et al. Recombinant activated factor VII in the treatment of bleeds and for the prevention of surgery-related bleeding in congenital haemophilia with inhibitors. Blood Rev 2015; 29 (Suppl 1):S9–S18.
Tran HT, Sorensen B, Rea CJ, et al. Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors. Haemophilia 2014; 20:369–375.
Howman R, Barnes C, Curtin J, et al. The clinical efficacy and safety of the FVIII/VWF concentrate, BIOSTATE(R), in children with von Willebrand disorder: a multi-centre retrospective review. Haemophilia 2011; 17:463–469.
Federici AB, Barillari G, Zanon E, et al. Efficacy and safety of highly purified, doubly virus-inactivated VWF/FVIII concentrates in inherited von Willebrand’s disease: results of an Italian cohort study on 120 patients characterized by bleeding severity score. Haemophilia 2010; 16:101–110.
Federici AB, Sacco R, Stabile F, Carpenedo M, Zingaro E, Mannucci PM. Optimising local therapy during oral surgery in patients with von Willebrand disease: effective results from a retrospective analysis of 63 cases. Haemophilia 2000; 6:71–77.
Reale SC, Farber MK, Lumbreras-Marquez MI, Connors JM, Carabuena JM. Anesthetic Management of Von Willebrand Disease in Pregnancy: A Retrospective Analysis of a Large Case Series. Anesth Analg. 2021 Nov 1;133(5):1244-1250. doi: 10.1213/ANE.0000000000005502.
Peterson W, Tse B, Martin R, Fralick M, Sholzberg M. Evaluating hemostatic thresholds for neuraxial anesthesia in adults with hemorrhagic disorders and tendencies: A scoping review. Res Pract Thromb Haemost. 2021 May 4;5(4):e12491. doi: 10.1002/rth2.12491.
Baouahi H, Zerqouni Y, Doumiri M, Oudghiri N, Saoud AT. Le rôle du médecin anesthésiste-réanimateur dans la prise en charge de la femme enceinte porteuse de la maladie de Von Willebrand [The role of the anesthesiologist in the care of the pregnant woman with Von Willebrand Disease]. Pan Afr Med J. 2015 Dec 4;22:335. French. doi: 10.11604/pamj.2015.22.335.7997
DiStefano YE, Lazar MD. Successful Ultrasound-Guided Femoral Nerve Blockade and Catheterization in a Patient with Von Willebrand Disease. Case Rep Anesthesiol. 2015;2015:106306. doi: 10.1155/2015/106306
Neff AT, Sidonio RF Jr. Management of VWD. Hematology Am Soc Hematol Educ Program 2014; 2014:536–541.
Hauser CJ, Boffard K, Dutton R et al. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma. 2010; 69(3):489–500.
Knudson MM, Cohen MJ, Reidy R et al. Trauma, transfusions, and use of recombinant factor VIIa: a multicenter case registry report of 380 patients from the Western Trauma Association. J Am Coll Surg. 2011; 212(1):87–95.
Mitra B, Cameron PA, Parr MJ, Phillips L. Recombinant factor VIIa in trauma patients with the ‘triad of death’. Injury. 2012; 43(9):1409–14.
Hahn RG. Adverse effects of crystalloid and colloid fluids. Anaesthesiol Intensive Ther. 2017;49(4):303-308. http://doi:10.5603/AIT.a2017.0045
Gillissen A, van den Akker T, Caram-Deelder C, et al. Association between fluid management and dilutional coagulopathy in severe postpartum haemorrhage: a nationwide retrospective cohort study. BMC Pregnancy Childbirth. 2018;18(1):398. Published 2018 Oct 11. http://doi:10.1186/s12884-018-2021-9
Henriquez DDCA, Bloemenkamp KWM, Loeff RM, et al. Fluid resuscitation during persistent postpartum haemorrhage and maternal outcome: A nationwide cohort study. Eur J Obstet Gynecol Reprod Biol. 2019;235:49-56. http://doi:10.1016/j.ejogrb.2019.01.027
Getrajdman C, Sison M, Lin HM, Katz D. The impact of crystalloid versus colloid on coagulation as measured by thromboelastometry in term parturients: an in vitro study. J Matern Fetal Neonatal Med. 2021 May 20:1-8. http://doi:10.1080/14767058.2021.1929157.
Boyd CJ, Brainard BM, Smart L. Intravenous Fluid Administration and the Coagulation System. Front Vet Sci. 2021 Apr 15;8:662504. http://doi:10.3389/fvets.2021.662504.
Schol PBB, de Lange NM, Woiski MD, Langenveld J, Smits LJM, Wassen MM, Henskens YM, Scheepers HCJ. Restrictive versus liberal fluid resuscitation strategy, influence on blood loss and hemostatic parameters in mild obstetric hemorrhage: An open-label randomized controlled trial. (REFILL study). PLoS One. 2021 Jun 25;16(6):e0253765. http://doi:10.1371/journal.pone.0253765.
Sevcikova S, Vymazal T, Durila M. Effect of Balanced Crystalloid, Gelatin and Hydroxyethyl Starch on Coagulation Detected by Rotational Thromboelastometry In Vitro. Clin Lab. 2017 Oct 1;63(10):1691-1700. http://doi:10.7754/Clin.Lab.2017.170505.
Ho KM, Leonard AD. Concentration-dependent effect of hypocalcaemia on mortality of patients with critical bleeding requiring massive transfusion: a cohort study. Anaesth Intensive Care. 2011; 39(1):46–54.
Moore HB, Tessmer MT, Moore EE, Sperry JL, Cohen MJ, Chapman MP, Pusateri AE, Guyette FX, Brown JB, Neal MD, Zuckerbraun B, Sauaia A. Forgot calcium? Admission ionized-calcium in two civilian randomized controlled trials of prehospital plasma for traumatic hemorrhagic shock. J Trauma Acute Care Surg. 2020 May;88(5):588-596. http://doi:10.1097/TA.0000000000002614.
Byerly S, Inaba K, Biswas S, Wang E, Wong MD, Shulman I, Benjamin E, Lam L, Demetriades D. Transfusion-Related Hypocalcemia After Trauma. World J Surg. 2020 Nov;44(11):3743-3750. http://doi:10.1007/s00268-020-05712-x.
Chanthima P, Yuwapattanawong K, Thamjamrassri T, Nathwani R, Stansbury LG, Vavilala MS, Arbabi S, Hess JR. Association Between Ionized Calcium Concentrations During Hemostatic Transfusion and Calcium Treatment With Mortality in Major Trauma. Anesth Analg. 2021 Jun 1;132(6):1684-1691. http://doi:10.1213/ANE.0000000000005431.
Chung HS, Cho SJ, Park CS. Effects of liver function on ionized hypocalcaemia following rapid blood transfusion. J Int Med Res. 2012;40(2):572-82. http://doi:10.1177/147323001204000219.
Napolitano LM. Hemostatic defects in massive transfusion: an update and treatment recommendations. Expert Rev Hematol. 2021 Feb;14(2):219-239. http://doi:10.1080/17474086.2021.1858788. Epub 2021 Jan 6. PMID: 33267678.
Ditzel RM Jr, Anderson JL, Eisenhart WJ, Rankin CJ, DeFeo DR, Oak S, Siegler J. A review of transfusion-and trauma-induced hypocalcemia: Is it time to change the lethal triad to the lethal diamond? J Trauma Acute Care Surg. 2020 Mar;88(3):434-439. http://doi:10.1097/TA.0000000000002570.
Hall C, Nagengast AK, Knapp C, Behrens B, Dewey EN, Goodman A, Bommiasamy A, Schreiber M. Massive transfusions and severe hypocalcemia: An opportunity for monitoring and supplementation guidelines. Transfusion. 2021 Jul;61 Suppl 1:S188-S194. http://doi:10.1111/trf.16496.
DeBot M, Sauaia A, Schaid T, Moore EE. Trauma-induced hypocalcemia. Transfusion. 2022 Aug;62 Suppl 1:S274-S280. doi: 10.1111/trf.16959.
Lier H, Krep H, Schroeder S, Stuber F. Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma. 2008; 65(4):951–60.
Perkins JG, Cap AP, Weiss BM et al. Massive transfusion and nonsurgical hemostatic agents. Crit Care Med. 2008; 36(7 Suppl):S325–39.
Rajagopalan S, Mascha E, Na J, Sessler DI. The effects of mild perioperative hypothermia on blood loss and transfusion requirement. Anesthesiology. 2008 Jan;108(1):71-7. http://doi:10.1097/01.anes.0000296719.73450.52.
Alam HB, Pusateri AE, Kindzelski A, Egan D, et al. HYPOSTAT workshop participants. Hypothermia and hemostasis in severe trauma: A new crossroads workshop report. J Trauma Acute Care Surg. 2012 Oct;73(4):809-17. http://doi:10.1097/TA.0b013e318265d1b8.
Wang CH, Chen NC, Tsai MS, Yu PH, et al. Therapeutic Hypothermia and the Risk of Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore). 2015 Nov;94(47):e2152. http://doi:10.1097/MD.0000000000002152.
Simegn GD, Bayable SD, Fetene MB. Prevention and management of perioperative hypothermia in adult elective surgical patients: A systematic review. Ann Med Surg (Lond). 2021 Nov 14;72:103059. http://doi:10.1016/j.amsu.2021.103059.
Harvey CJ. Evidence-Based Strategies for Maternal Stabilization and Rescue in Obstetric Hemorrhage. AACN Adv Crit Care. 2018;29(3):284-294. http://doi:10.4037/aacnacc2018966
Kander T, Schött U. Effect of hypothermia on haemostasis and bleeding risk: a narrative review. J Int Med Res. 2019;47(8):3559-3568. http://doi:10.1177/0300060519861469
Quine EJ, Murray L, Trapani T, Cooper DJ. Thromboelastography to Assess Coagulopathy in Traumatic Brain Injury Patients Undergoing Therapeutic Hypothermia. Ther Hypothermia Temp Manag. 2021 Mar;11(1):53-57. doi: 10.1089/ther.2020.0025.